期刊文献+

EGFR及VEGF在汉族与维吾尔族女性三阴性乳腺癌中的表达差异分析 被引量:8

The differences in expressions of EGFR and VEGF between Han and Uygur triple-negative breast cancer patients
下载PDF
导出
摘要 背景与目的:三阴性乳腺癌(triple-negative breast cancer,TNBC)是目前乳腺癌研究关注的焦点。有研究显示,不同民族其分子生物学特征也不尽相同。该研究旨在分析汉族及维吾尔族女性TNBC患者表皮生长因子受体(epidermal growth factor receptor,EGFR)、血管内皮生长因子(vascular endothelial growth factor,VEGF)的表达情况,了解其与预后间的关系。方法:选择新疆医科大学附属肿瘤医院2007年1月—2009年1月收治的汉族、维吾尔族女性TNBC患者167例,其中汉族患者121例,维吾尔族患者46例,应用PV-9000免疫组织化学染色方法测定其EGFR、VEGF的表达状态,并与淋巴结转移情况及临床分期进行比较,结果采用用SPSS 18.0统计软件进行分析。结果:汉族与维吾尔族女性患者在5年无病生存期方面差异无统计学意义(P>0.05);同时汉族患者EGFR、VEGF阳性率低于维吾尔族患者(P<0.05),并且其表达均与TNM分期及淋巴结转移呈正相关(0<r<1,P<0.05)。结论:汉族女性TNBC患者EGFR、VEGF的阳性率低于维吾尔族女性患者,但两组5年无病生存期差异无统计学意义(P>0.05),提示维吾尔族TNBC患者可能存在与汉族患者不同的影响其预后的因素,需开展进一步研究证实。 Background and purpose: Triple-negative breast cancer (TNBC) is currently the focus of breast cancer research. Researches demonstrated that the molecular biological characteristics of different ethnic groups are not the same. This study mainly probed into the expression of endothelial growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) in Han and Uygur TNBC patients, and the relationship between the expression and prognosis of patients. Methods: From Jan. 2007 to Jan. 2009, 167 patients were admitted. Among those, 121 were Han and 46 were Uygur patients. The expressions of EGFR, and VEGF were detected by PV-9000 immunohistochemical staining, and compared with lymph node metastasis and clinical staging. The results were analyzed by SPSS 18.0 statistical software. Results: Five-year disease-free survival (DFS) of two groups had no indifferent (P〉0.05). EGFR and VEGF positive rate of Han patients was lower than that of Uygur patients (P〈0.05). Their expressions were correlated with TNM staging and lymph node metastasis (0〈r〈l,P〈0.05), Conclusion: This study found that the EGFR and VEGF expression rate which was unfavorable to prognosis of TNBC patients was lower in the Uygur group than that in the Han group. However, no significant difference in 5-year DFS was found between the two groups (P〉0.05). Uygur TNBC patients might have a different prognostic factor as compared with Hart patients. Further studies need to be carried out.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2016年第5期404-408,共5页 China Oncology
基金 国家自然科学基金(81260390) 新疆维吾尔自治区科技厅科技支疆项目(2013911116)
关键词 表皮生长因子受体 血管内皮生长因子 汉族 维吾尔族 三阴性乳腺癌 Endothelial growth factor receptor Vascular endothelial growth factor Han Uygur Triple-negative breast cancer
  • 相关文献

参考文献11

  • 1PEROU C M, SORLIE T, EISEN M B, et al. Molecular portraits of human breast tumours [ J ] . Nature, 2000, 406(6797): 747-752. 被引量:1
  • 2SLIWKOWSKI M X, MELLMAN I. Antibody therapeutics in cancer [ J ] . Science, 2013, 341(6151): 1192-1198. 被引量:1
  • 3NIELSEN T O, HSU F D, JENSEN K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [ J ] . Clin Cancer Res, 2004, 10 (16): 5367-5374. 被引量:1
  • 4KIM M S, PARK T I, LEE Y M, et al. Expression of id-1 and VEGF in non-small cell lung cancer [ J ] . Int J Clin Exp Pathol, 2013, 6(10): 2012-2111. 被引量:1
  • 5GREENBERG S, RUHO H S. Triple-negative breast cancer: role of antiangiogenic agents [ J ] . Cancer J, 2010, 16(1): 33-38. 被引量:1
  • 6LINDERHOLM B K, HELLBORG H, JOHANSSON U, et al. Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer [ J ] . Ann Oncol, 2009, 20(10): 1639-1646. 被引量:1
  • 7RYDEN L, JIRSTROM K, HAGLUND M, et al. Epidermal growth factor receptor and vascular endothelial growth factor receptor-2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trim with long- term follow-up [ J ] . Breast Cancer Res Treat, 2010, 120(2): 491-498. 被引量:1
  • 8杨艳芳,刘君,姜战胜,顾林.VEGF 在三阴性乳腺癌中的表达及临床意义[J].中国肿瘤临床,2012,29(8):439-442. 被引量:15
  • 9RAKHA E A, EI-SAYED M E, GREEN A R, et al. prognostic markers in triple-negative breast cancer [ J ] . Cancer, 2007, 109(1): 25-32. 被引量:1
  • 10JOBIM F C, SCHWARTSMANN G, XAVIER N L, et al. Expression of MMP-9 and VEGF in breast cancer: eorrelation with other prognostie indieators [ J ] . Rev Bras Gineeol Obstet, 2008, 30(6): 287-293. 被引量:1

二级参考文献17

  • 1Bauer KR,Brown M,Cress RD,et al.Descriptive analysis of estrogen receptor (ER)-negative,progesterone receptor (PR)-negative,and HER2-negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the California cancer Registry[J].Cancer,2007,109(9):1721-1728. 被引量:1
  • 2Cleator S,Heller W,Coombes RC.Triple-negative breast cancer:therapeutic options[J].Lancet Oncol,2007,8(3):235-244. 被引量:1
  • 3Rakha EA,El-Sayed ME,Green AR,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109(1):25-32. 被引量:1
  • 4Haffty BG,Yang Q,Reiss M,et al.Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer[J].J Clin Oncol,2006,24(36):5652-5657. 被引量:1
  • 5Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breast cancer:clinical features and patterns of recurrence[J].Clin Cancer Res,2007,13(15Pt1):4429-4434. 被引量:1
  • 6Shivakumar S,Prabhakar BT,Jayashree K,et al.Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density(MVD) as prognostic indicators in carcinoma breast[J].J Cancer Res Clin Oncol,2009,135 (4):627-636. 被引量:1
  • 7Linderholm B,Tavelin B,Grankvist K,et al.Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma[J].J Clin Oncol,1998,16(9):3121-3128. 被引量:1
  • 8Kowanetz M,Ferrara N.Vascular endothelial growth factor signaling pathways:therapeutic perspective[J].Clin Cancer Res,2006,12 (17):5018-5022. 被引量:1
  • 9Linderholm BK,Hellborg H,Johansson U,et al.Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer[J].Ann Oncol,2009,20(10):1639-1646. 被引量:1
  • 10Jobim FC,Schwartsmann G,Xavier NL,et al.Expression of MMP-9 and VEGF in breast cancer:correlation with other prognostic indicators[J].Rev Bras Ginecol Obstet,2008,30(6):287-293. 被引量:1

共引文献14

同被引文献81

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部